A recent multinational, federated analysis of LEGEND-T2DM study published that Sodium-glucose cotransporter 2 inhibitors ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

With weight-loss injectables now being sold at Costco and other major retailers, drugs like Ozempic are becoming more ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

The overall findings from the landmark FLOW trial confirmed the potential of glucagon-like peptide 1 (GLP-1) receptor ...

Support for the neurokinin-1 receptor (NK1R) antagonist included a negative phase III trial and a positive phase II study ...

Amsterdam, Netherlands) A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in ...

Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments ...